BioCentury
ARTICLE | Company News

Algeta, Bayer deal

July 26, 2010 7:00 AM UTC

Algeta will receive a €5 million ($6.5 million) milestone payment from Bayer under a 2009 deal in which the companies partnered to develop and commercialize Algeta's Alpharadin. The payment was trigg...